Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The effects of fentanyl, alfentanil and remifentanil on the cardiovascular responses during rigid bronchoscopy
Source of recordUK Trials
ISRCTNISRCTN31439885
Date ISRCTN assigned30/09/2005
Local reference number(s)N0185146397
Public titleThe effects of fentanyl, alfentanil and remifentanil on the cardiovascular responses during rigid bronchoscopy
Scientific title
AcronymN/A
Disease/condition/study domainCardiovascular:
Study hypothesisWe are planning to investigate the effects of fentanyl, alfentanil and remifentanil on the cardiovascular responses during rigid bronchoscopy.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria60 adults
Participants - exclusion criteriaUntreated systemic hypertension with SABP>160mmHg and /or DABP> 105mm Hg
Arythmias and heart conduction defects
Severe bronchial asthma.
Patient information material
Anticipated start date25/09/2003
Anticipated end date25/03/2004
Status of trialCompleted
Target number of participants60
InterventionsPatients undergoing rigid bronchoscopy will be randomised into the three drug groups , measurement of muscle relaxation, arterial blood pressure and heart rate.
Primary outcome measure(s)Changes in arterial blood pressures and heart rate.
Secondary outcome measure(s)See Primary outcome measures
Sources of fundingPlymouth Hospitals NHS Trust

NHS R&D Support Funding
Sponsor nameRecord Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameDr S Dudnikov
Contact detailsDepartment of Anaesthesia
Derriford Hospital


Plymouth
United Kingdom
PL6 8DH
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN31439885
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central